Assessment of vascular function in patients with chronic kidney disease

Journal of Visualized Experiments

Volumn , Issue 88, 2014, Pages

  Jablonski, Kristen L ^a   Decker, Emily ^a   Perrenoud, Loni ^a   Kendrick, Jessica ^a   Chonchol, Michel ^a   Seals, Douglas R ^b   Jalal, Diana ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY OF COLORADO   (United States)

Author keywords

Chronic kidney disease; Endothelial cells; Flow mediated dilation; Immunofluorescence; Issue 88; Medicine; Oxidative stress; Pulse wave velocity

Indexed keywords

EID: 84929315124     PISSN: 1940087X     EISSN: None     Source Type: Journal    
DOI: 10.3791/51478     Document Type: Article

References (50)

1. Levey, A. S. et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 150, 604-612 (2009).
2. Foley, R. N., Parfrey, P. S., & Sarnak, M. J. Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol. 9, S16-23 (1998).
3. Parfrey, P. S., & Harnett, J. D. Cardiac disease in chronic uremia. Pathophysiology and clinical epidemiology. Asaio J. 40, 121-129 (1994).
4. Schiffrin, E. L., Lipman, M. L., & Mann, J. F. Chronic kidney disease: effects on the cardiovascular system. Circulation. 116, 85-97 (2007).
5. Sarnak, M. J. et al. Cardiovascular disease risk factors in chronic renal insufficiency. Clin Nephrol. 57, 327-335 (2002).
6. Kendrick, J., & Chonchol, M. B. Nontraditional risk factors for cardiovascular disease in patients with chronic kidney disease. Nat Clin Pract Nephrol. 4, 672-681 (2008).
7. Bellasi, A., Ferramosca, E., & Ratti, C. Arterial stiffness in chronic kidney disease: the usefulness of a marker of vascular damage. Int J Nephrol. 2011, 734832 (2011).
8. van der Zee, S., Baber, U., Elmariah, S., Winston, J., & Fuster, V. Cardiovascular risk factors in patients with chronic kidney disease. Nat Rev Cardiol. 6, 580-589 (2009).
9. Malyszko, J. Mechanism of endothelial dysfunction in chronic kidney disease. Clinica chimica acta; international journal of clinical chemistry. 411, 1412-1420 (2010).
10. Lakatta, E. G., & Levy, D. Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part I: aging arteries: a "set up" for vascular disease. Circulation.107, 139-146 (2003).
11. Seals, D. R., Jablonski, K. L., & Donato, A. J. Aging and vascular endothelial function in humans. Clin Sci (Lond). 120, 357-375 (2011).
12. Jablonski, K. L. et al. Dietary sodium restriction reverses vascular endothelial dysfunction in middle-aged/older adults with moderately elevated systolic blood pressure. J Am Coll Cardiol. 61, 335-343 (2013).
13. Briet, M. et al. Arterial stiffness and enlargement in mild-to-moderate chronic kidney disease. Kidney Int. 69, 350-357 (2006).
14. Thambyrajah, J. et al. Abnormalities of endothelial function in patients with predialysis renal failure. Heart. 83, 205-209 (2000).
15. Ghiadoni, L. et al. Effect of acute blood pressure reduction on endothelial function in the brachial artery of patients with essential hypertension. J Hypertens. 19, 547-551 (2001).
16. Yilmaz, M. I. et al. The determinants of endothelial dysfunction in CKD: oxidative stress and asymmetric dimethylarginine. Am J Kidney Dis. 47, 42-50 (2006).
17. Wang, M. C., Tsai, W. C., Chen, J. Y., & Huang, J. J. Stepwise increase in arterial stiffness corresponding with the stages of chronic kidney disease. Am J Kidney Dis. 45, 494-501 (2005).
18. Shinohara, K. et al. Arterial stiffness in predialysis patients with uremia. Kidney Int. 65, 936-943 (2004).
19. Karras, A. et al. Large artery stiffening and remodeling are independently associated with all-cause mortality and cardiovascular events in chronic kidney disease. Hypertension, 60, 1451-7 (2012).
20. Pannier, B., Guerin, A. P., Marchais, S. J., Safar, M. E., & London, G. M. Stiffness of capacitive and conduit arteries: prognostic significance for end-stage renal disease patients. Hypertension. 45, 592-596 (2005).
21. Yilmaz, M. I. et al. Vascular health, systemic inflammation and progressive reduction in kidney function; clinical determinants and impact on cardiovascular outcomes. Neprhol Dial Transplant. 26, 3537-3543, doi:10.1093/ndt/gfr081 (2011).
22. Sutton-Tyrrell, K. et al. Elevated aortic pulse wave velocity, a marker of arterial stiffness, predicts cardiovascular events in well-functioning older adults. Circulation. 111, 3384-3390 (2005).
23. Tanaka, H., DeSouza, C. A., & Seals, D. R. Absence of age-related increase in central arterial stiffness in physically active women. Arterioscler Thromb Vasc Biol. 18, 127-132 (1998).
24. Mitchell, G. F. et al. Arterial stiffness and cardiovascular events: the Framingham Heart Study. Circulation. 121, 505-511 (2010).
25. Yeboah, J., Crouse, J. R., Hsu, F. C., Burke, G. L., & Herrington, D. M. Brachial flow-mediated dilation predicts incident cardiovascular events in older adults: the Cardiovascular Health Study. Circulation. 115, 2390-2397 (2007).
26. Shechter, M. et al. Long-term association of brachial artery flow-mediated vasodilation and cardiovascular events in middle-aged subjects with no apparent heart disease. Int J Cardiol. 134, 52-58 (2009).
27. Baylis, C. Nitric oxide deficiency in chronic kidney disease. Am J Physiol Renal Physiol. 294, F1-9 (2008).
28. Wever, R. et al. Nitric oxide production is reduced in patients with chronic renal failure. Arterioscler Thromb Vasc. 19, 1168-1172 (1999).
29. Endemann, D. H., & Schiffrin, E. L. Endothelial dysfunction. J Am Soc Nephrol. 15, 1983-1992 (2004).
30. Hasdan, G. et al. Endothelial dysfunction and hypertension in 5/6 nephrectomized rats are mediated by vascular superoxide. Kidney Int. 61, 586-590 (2002).
31. Chue, C. D., Townend, J. N., Steeds, R. P., & Ferro, C. J. Arterial stiffness in chronic kidney disease: causes and consequences. Heart. 96, 817-823 (2010).
32. Dupont, J. J., Farquhar, W. B., Townsend, R. R., & Edwards, D. G. Ascorbic acid or L-arginine improves cutaneous microvascular function in chronic kidney disease. J Appl Physiol. 111 (2011).
33. Oberg, B. P. et al. Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease. Kidney Int. 65, 1009-1016 (2004).
34. Cachofeiro, V. et al. Oxidative stress and inflammation, a link between chronic kidney disease and cardiovascular disease. Kidney Int Suppl (111), S4-9 (2008).
35. Vila, E., & Salaices, M. Cytokines and vascular reactivity in resistance arteries. Am J Physiol Heart Circ Physiol. 288, H1016-1021 (2005).
36. Perticone, F. et al. Endothelial dysfunction and subsequent decline in glomerular filtration rate in hypertensive patients. Circulation. 122, 379-384 (2010).
37. Zatz, R., & Baylis, C. Chronic nitric oxide inhibition model six years on. Hypertension. 32, 958-964 (1998).
38. Nakagawa, T., & Johnson, R. J. Endothelial nitric oxide synthase. Contrib Nephrol. 170, 93-101 (2011).
39. Muller, V., Tain, Y. L., Croker, B., & Baylis, C. Chronic nitric oxide deficiency and progression of kidney disease after renal mass reduction in the C57Bl6 mouse. Am J Nephrol.32, 575-580 (2010).
40. Colombo, P. C. et al. Biopsy coupled to quantitative immunofluorescence: a new method to study the human vascular endothelium. J Appl Physiol. 92, 1331-1338 (2002).
41. Donato, A. J., Black, A. D., Jablonski, K. L., Gano, L. B., & Seals, D. R. Aging is associated with greater nuclear NFkappaB, reduced IkappaBalpha, and increased expression of proinflammatory cytokines in vascular endothelial cells of healthy humans. Aging Cell. 7, 805-812 (2008).
42. Donato, A. J. et al. Direct evidence of endothelial oxidative stress with aging in humans: relation to impaired endothelium-dependent dilation and upregulation of nuclear factor-kappaB. Circ Res 100, 1659-1666 (2007).
43. Jablonski, K. L., Chonchol, M., Pierce, G. L., Walker, A. E., & Seals, D. R. 25-Hydroxyvitamin D deficiency is associated with inflammation-linked vascular endothelial dysfunction in middle-aged and older adults. Hypertension. 57, 63-69, (2011).
44. Corretti, M. C. et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol. 39, 257-265 (2002).
45. Harris, R. A., Nishiyama, S. K., Wray, D. W., & Richardson, R. S. Ultrasound assessment of flow-mediated dilation. Hypertension. 55, 1075-1085 (2010).
46. Donald, A. E. et al. Methodological approaches to optimize reproducibility and power in clinical studies of flow-mediated dilation. J Am Coll Cardiol. 51, 1959-1964 (2008).
47. Widlansky, M. E. Shear stress and flow-mediated dilation: all shear responses are not created equally. Am J Physiol Heart Circ Physiol. 296, H31-32 (2009).
48. Stewart, A. D., Millasseau, S. C., Kearney, M. T., Ritter, J. M., & Chowienczyk, P. J. Effects of inhibition of basal nitric oxide synthesis on carotid-femoral pulse wave velocity and augmentation index in humans. Hypertension. 42, 915-918 (2003).
49. Lantelme, P., Mestre, C., Lievre, M., Gressard, A., & Milon, H. Heart rate: an important confounder of pulse wave velocity assessment. Hypertension. 39, 1083-1087 (2002).
50. Jablonski, K. L., Seals, D. R., Eskurza, I., Monahan, K. D., & Donato, A. J. High-dose ascorbic acid infusion abolishes chronic vasoconstriction and restores resting leg blood flow in healthy older men. J Appl Physiol. 103, 1715-1721 (2007).